معرفی
Pascal Borry is a Full Professor at KU Leuven Faculty of Medicine in Leuven, Belgium, where he leads a research group focused on bioethics and medical ethics. His work bridges the gap between advancing genomic technologies and the ethical considerations they raise in clinical practice and research.
Professor Borry's research interests center on the ethical implications of genomic medicine, with particular expertise in informed consent processes (especially electronic informed consent), direct-to-consumer genetic testing, reproductive genetic carrier screening, and genomic data sharing. His work addresses critical questions about how to balance patient autonomy, privacy concerns, and the need for advancing medical knowledge through genomic research.
Analysis of Professor Borry's recent publications (2024-2025) reveals a consistent focus on emerging ethical challenges in genomic medicine. His work spans bioethics, health policy, and clinical genetics, with particular attention to practical implementation issues. Key trends include examining regional disparities in access to genetic therapies, ethical considerations in deception research, and the evolving landscape of reproductive genetic screening. His research often takes a comparative approach across different healthcare systems.
Professor Borry has established himself as a leading researcher in medical ethics with 329 publications and over 9,000 citations. His work demonstrates consistent engagement with evolving ethical challenges in genomic medicine, particularly focusing on practical implementation issues rather than purely theoretical discussions. He frequently collaborates with healthcare professionals, researchers, and policymakers to address real-world ethical dilemmas.
Professor Borry's research group appears to focus on practical ethical issues emerging from advances in genomic technologies. His work often involves engaging with healthcare professionals, patients, and policymakers to develop practical guidance for navigating complex ethical terrain in genomic medicine. His research demonstrates how ethical frameworks can be developed to support both innovation in genomic medicine and protection of patient rights and interests.
